Meeder Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Meeder Advisory Services's GILD Position: Q2 2026 in Review
Meeder Advisory Services reduced its Gilead Sciences (GILD) stake by 2.4% in Q2 2026, selling an estimated $112K and leaving 34,965 shares worth $4.42M. The position accounts for 0.16% of the portfolio, ranked #86.
Meeder Advisory Services first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.99M in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Meeder Advisory Services held 34,965 shares of Gilead Sciences worth $4.42M as of Q2 2026.
- Meeder Advisory Services sold 847 Gilead Sciences shares in Q2 2026, an estimated $112K.
- Gilead Sciences made up 0.16% of Meeder Advisory Services's portfolio in Q2 2026, its #86 holding.
- Meeder Advisory Services first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
- Meeder Advisory Services's Gilead Sciences position peaked at $4.99M in Q1 2026.
- 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.